title: Revascularization in atherosclerotic renovascular disease: problems beyond the obstruction.
abstract: The main goal in the treatment of obstructive atherosclerotic renovascular disease (ARVD) is to preserve or recover renal function. The ARVD kidney continues to deteriorate in 20-40% of cases despite restoration of blood flow. Holden et al. report that renal function stabilized or improved in up to 97% of patients with the use of a distal embolic protection device.
authors.affiliation: Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. chade.alejandro@mayo.edu
authors.forename: A R
authors.initials: AR
authors.lastname: Chade
mesh_terms: D000800:Angioplasty, Balloon / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D050197:Atherosclerosis / Q000150:complications* / Q000628:therapy*; D002404:Catheterization / Q000295:instrumentation / Q000379:methods; D018450:Disease Progression; D004617:Embolism / Q000517:prevention & control*; D006801:Humans; D007668:Kidney / Q000098:blood supply / Q000503:physiopathology; D012039:Regional Blood Flow / Q000502:physiology; D012078:Renal Artery Obstruction / Q000503:physiopathology / Q000628:therapy*; D015607:Stents